GTR 106029185
Bids Are Invited For Registration Of Prices For The Eventual Hiring Of A Specialized Company To Supply Medicines Intended To Supply The Municipal Basic Pharmacy, And For The Small Hospital Pharmacy, Covering The Items That Had A Failed And Insufficient Process In The Tender Carried Out By The Intermunicipal Consortium (Conivales), As Well As The Other Medicines That Were Not Included In The Tender, Aiming To Ensure The Continuity Of Pharmaceutical Service To The Population To Meet The Needs Of The Municipal Health Fund Of Umbaúba/Se
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
106029185
Tendering Authority
Subscribe to view
Tender No
010/2025
Financer Name
Self-Funded
Work Title
Bids Are Invited For Registration Of Prices For The Eventual Hiring Of A Specialized Company To Supply Medicines Intended To Supply The Municipal Basic Pharmacy, And For The Small Hospital Pharmacy, Covering The Items That Had A Failed And Insufficient Process In The Tender Carried Out By The Intermunicipal Consortium (Conivales), As Well As The Other Medicines That Were Not Included In The Tender, Aiming To Ensure The Continuity Of Pharmaceutical Service To The Population To Meet The Needs Of The Municipal Health Fund Of Umbaúba/Se
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
29-12-2025
Closed
Work Detail
Acetylcysteine Injectable Solution 100Mg/Ml. Specification: Acetylcysteine Injectable Solution 100Mg/Ml Presentation Ampoule With 3Ml., Acetylcysteine. Concentration/Composition: 40 Mg/Ml. Specification: Pharmaceutical Form: Adult Syrup. 120 Ml Bottle + Graduated Dispenser., Ascorbic Acid. Concentration/Composition: 100 Mg/Ml. Pharmaceutical Form: Injectable Solution. Ampoule 5 Ml. Specification: Ascorbic Acid. Concentration/Composition: 100 Mg/Ml. Pharmaceutical Form: Injectable Solution. Ampoule 5 Ml., Tranexamic Acid. Concentration/Composition: 50 Mg/Ml. Specification: Tranexamic Acid. Concentration/Composition: 50 Mg/Ml. Pharmaceutical Form: Injectable Solution. Colorless Glass Ampoule Containing 5 Ml., Folic Acid. Concentration/Composition: 0.2 Mg/Ml. Specification: Folic Acid. Concentration/Composition: 0.2 Mg/Ml. Pharmaceutical Form: Oral Solution. Bottle With Dripper Containing 30 Ml., 09/12/2025 - 15:28:11, 09/12/2025 - 15:28:12, Adenosine. Concentration/Composition: 3 Mg/Ml. Specification: Adenosine. Concentration/Composition: 3 Mg/Ml. Pharmaceutical Form: Injectable Solution. Ampoule With 2 Ml., Atenolol. Concentration/Composition: 100 Mg. Specification: Atenolol. Concentration/Composition: 100 Mg. Pharmaceutical Form: Capsule Or Tablet. Unit., Azithromycin Dihydrateconcentration/Composition: 500 Mg. Specification: Azithromycin Dihydrateconcentration/Composition: 500 Mg Pharmaceutical Form: Lyophilized Powder For Injectable Solution, Intravenouspresentation: Ampoule Vial, Benzathine Benzylpenicillin. Concentration/Composition: 1,200,000 Iu. Specification: Benzathine Benzylpenicillin. Concentration/Composition: 1,200,000 Iu. Pharmaceutical Form: Injectable Suspension. Colorless Glass Ampoule Bottle (4 Ml)., Sodium Bicarbonate. Concentration/Composition: 1 Meq/Ml (8.4%). Specification: Sodium Bicarbonate. Concentration/Composition: 1 Meq/Ml (8.4%). Pharmaceutical Form: Injectable Solution. Transparent Plastic Ampoule Containing 10 Ml., Biperiden Concentration/Composition: 5Mg/Ml Injectable Solution. Specification: Biperiden Concentration/Composition: 5Mg/Ml Injectable Solution, Intramuscular Or Intravenous Use Presentation: 1Ml Ampoule, Bromazepam. Concentration/Composition: 6 Mg. Specification: Pharmaceutical Form: Tablet. Unit., Scopolamine Butylbromide + Dipyrone. Composition/Concentration: 10 Mg + 250 Mg. Specification: Scopolamine Butylbromide + Dipyrone. Composition/Concentration: 10 Mg + 250 Mg. Pharmaceutical Form: Tablet. Unit., Scopolamine Butylbromide + Dipyrone. Concentration/Composition; 6.67 + 333.4 Mg/Ml. Specification: Scopolamine Butylbromide + Dipyrone. Concentration/Composition; 6.4 Mg/Ml. Pharmaceutical Form: Oral Solution. 20 Ml Drip Bottle. Unit., Clonidine Concentration/Composition: 150 Mg/Ml. Specification: Clonidine Concentration/Composition: 150 Mg/Ml Pharmaceutical Form: 1 Ml Ampoule, Chlorpromazine Hydrochloride. Concentration/Composition: 5 Mg/Ml. Specification: Chlorpromazine Hydrochloride. Concentration/Composition: 5 Mg/Ml. Pharmaceutical Form: Injectable Solution. Amber Glass Ampoule Containing 5 Ml., Amiodarone Hydrochloride. Concentration/Composition: 50 Mg/Ml. Specification: Amiodarone Hydrochloride. Concentration/Composition: 50 Mg/Ml. Pharmaceutical Form: Injectable Solution. Amber Glass Ampoule Containing 03 Ml., Chlorpromazine Hydrochloride. Concentration/Composition: 100 Mg. Specification: Chlorpromazine Hydrochloride. Concentration/Composition: 100 Mg. Pharmaceutical Form: Capsule Or Tablet. Unit., Lidocaine Hydrochloride. Concentration
Key Value
Tender Value
430,312 - BRL
Tender Documents
Global Tender Document
e6c5b991-d167-4591-95a1-2a2c440aeabb.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.